News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anthera Pharmaceuticals, Inc. (ANTH) Reports 2013 First Quarter Financial Results


5/14/2013 6:57:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAYWARD, Calif., May 13, 2013 — /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st, 2013.

First Quarter 2013 Financial Results:

Loss from operations, which included a non-recurring and non-cash charge of approximately $1.5 million in stock-based compensation, was $6.9 million for the first quarter of 2013, compared to $20.1 million for the first quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at The Herald


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES